Peer-Reviewed Publication - 2 March 2025 From tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates Read Moreabout From tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates
Article - 19 March 2025 Analytical Validation of the Labcorp® Plasma Complete™ Test, a Cell-Free DNA Comprehensive Genomic Profiling Tool for Precision Oncology
Webinar - 19 March 2025 Molecular Tumor Board: 72-year-old male with HER2-overexpressed adenocarcinoma of the gastroesophageal junction
Webinar - 5 March 2025 The Impact of Prior Single-Gene Testing on Comprehensive Genomic Profiling Results, Practical Considerations for Personalized Cancer Care
Article - 19 March 2025 Analytical Validation of the Labcorp® Plasma Complete™ Test, a Cell-Free DNA Comprehensive Genomic Profiling Tool for Precision Oncology Read Moreabout Analytical Validation of the Labcorp® Plasma Complete™ Test, a Cell-Free DNA Comprehensive Genomic Profiling Tool for Precision Oncology
Webinar - 19 March 2025 Molecular Tumor Board: 72-year-old male with HER2-overexpressed adenocarcinoma of the gastroesophageal junction Read Moreabout Molecular Tumor Board: 72-year-old male with HER2-overexpressed adenocarcinoma of the gastroesophageal junction
Webinar - 5 March 2025 The Impact of Prior Single-Gene Testing on Comprehensive Genomic Profiling Results, Practical Considerations for Personalized Cancer Care Read Moreabout The Impact of Prior Single-Gene Testing on Comprehensive Genomic Profiling Results, Practical Considerations for Personalized Cancer Care
Peer-Reviewed Publication - 2 March 2025 From tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates Read Moreabout From tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates
Article - 27 February 2025 Graphical Summary: A consensus-based classification workflow to determine genetically inferred ancestry from comprehensive genomic profiling of patients with solid tumors Read Moreabout Graphical Summary: A consensus-based classification workflow to determine genetically inferred ancestry from comprehensive genomic profiling of patients with solid tumors
Webinar - 5 February 2025 Molecular Tumor Board: 47-year-old male with papillary thyroid cancer and BRAF V600E alteration Read Moreabout Molecular Tumor Board: 47-year-old male with papillary thyroid cancer and BRAF V600E alteration
Peer-Reviewed Publication - 30 January 2025 Fully automated extraction of high-quality total nucleic acids from FFPE specimens for comprehensive genomic profiling of solid tumors Read Moreabout Fully automated extraction of high-quality total nucleic acids from FFPE specimens for comprehensive genomic profiling of solid tumors
Peer-Reviewed Publication - 23 January 2025 Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258 Read Moreabout Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258
Peer-Reviewed Publication - 14 January 2025 Analytical Validation of the Labcorp Plasma Complete Test, a Cell-Free DNA Comprehensive Genomic Profiling Tool for Precision Oncology Read Moreabout Analytical Validation of the Labcorp Plasma Complete Test, a Cell-Free DNA Comprehensive Genomic Profiling Tool for Precision Oncology
27-30 Apr 2025 - American Association for Cancer Research® (AACR) Annual Meeting 2025 Join Labcorp in Chicago Read Moreabout Join Labcorp in Chicago